| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |